Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

LifeVantage Corp (NASDAQ:LFVN)

8.93
Delayed Data
As of Dec 08
 +0.66 / +7.98%
Today’s Change
6.43
Today|||52-Week Range
15.97
-6.20%
Year-to-Date
No recent news for LifeVantage Corp.

Today’s Trading

Previous close8.27
Today’s open8.27
Day’s range8.02 - 8.94
Volume182,533
Average volume (3 months)100,720
Market cap$116.0M
Dividend yield--
Data as of 4:00pm ET, 12/08/2016

Growth & Valuation

Earnings growth (last year)-30.00%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)-11.04%
P/E ratio31.9
Price/Sales0.28
Price/Book34.70

Competitors

 Today’s
change
Today’s
% change
CTSOCytosorbents Corp+0.15+2.88%
CDXCChromadex Corp+0.09+3.85%
NVLNNovelion Therapeutic...-0.01-0.56%
CDTXCidara Therapeutics ...+0.20+1.87%
Data as of 4:00pm ET, 12/08/2016

Financials

Last reporting dateAugust 30, 2016
EPS forecast (this quarter)--
Annual revenue (last year)$190.3M
Annual profit (last year)$7.0M
Net profit margin3.67%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
President, Chief Executive Officer &
Director
Darren Jensen
Chief Operating Officer
Robert M. Urban
Corporate headquarters
Sandy, Utah

Forecasts


Search for Jobs